Jurgen P.
- Country
- The Netherlands
- Department
- Neurology
Research Overview
- Noisy Rebels; Non-inferiority study of rituximab compared to ocrelizumab in relapsing MS
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- Evaluation of Personalized B Cell-Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 61 of 356 partner sites.
Specializations
Cerebrovascular Disorders
The investigator specializes in the treatment and prevention of intracerebral hemorrhage and various types of stroke conditions, with particular attention to both ischemic and hemorrhagic events.
- Intracerebral hemorrhage management
- Post-stroke antiplatelet therapy
- Cryptogenic stroke in young patients
Notable focus on antiplatelet therapy optimization in different stroke scenarios.
Multiple Sclerosis Treatment
Expert in multiple sclerosis therapeutic approaches, particularly focusing on innovative treatment strategies using targeted biological therapies.
- Personalized B-cell targeted therapy
- Anti-CD20 treatment protocols
- Comparative therapy assessment
Specialized in personalized treatment approaches and comparative effectiveness of MS therapies.
Preventive Neurology
Focuses on preventive strategies for neurological conditions, particularly in the context of stroke prevention and management of transient ischemic attacks.
- Secondary stroke prevention
- Novel anticoagulation approaches
- Risk management in TIA
Expertise in long-term management strategies for stroke prevention and recurrence reduction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.